Buy side seems to be stacked pretty heavily. No doubt jostling for position in case they like the news - will dissapear quicker than a brides' nighty if they don't like the news.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%